Jia Yu

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Signal transduction and targeted therapy

Molecular cancer research : MCR

Future oncology (London, England)

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Chao Zhang, Qiang Guo, Lifeng Chen, Zheming Wu, Xiao-Jian Yan, Chengyang Zou, Qiuxue Zhang, Jiahong Tan, Tian Fang, Qunxian Rao, Yang Li, Shizhen Shen, Min Deng, Liewei Wang, Huanyao Gao, Jia Yu, Hu Li, Cheng Zhang, Somaira Nowsheen, Jake A Kloeber, Fei Zhao, Ping Yin, Chunbo Teng, Zhongqiu Lin, Kun Song, Shuzhong Yao, Liangqing Yao, Lingying Wu, Yong Zhang, Xiaodong Cheng, Qing-Lei Gao, Jian Yuan, Zhenkun Lou, Jin-San Zhang
A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors. Signal transduction and targeted therapy 8 (1) (2023)
Chao Zhang, Qiang Guo, Lifeng Chen, Zheming Wu, Xiao-Jian Yan, Chengyang Zou, Qiuxue Zhang, Jiahong Tan, Tian Fang, Qunxian Rao, Yang Li, Shizhen Shen, Min Deng, Liewei Wang, Huanyao Gao, Jia Yu, Hu Li, Cheng Zhang, Somaira Nowsheen, Jake A Kloeber, Fei Zhao, Ping Yin, Chunbo Teng, Zhongqiu Lin, Kun Song, Shuzhong Yao, Liangqing Yao, Lingying Wu, Yong Zhang, Xiaodong Cheng, Qing-Lei Gao, Jian Yuan, Zhenkun Lou, Jin-San Zhang
A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors. Signal transduction and targeted therapy 8 (1) (2023)
Lei Sun, Jia Yu, Justin Guinney, Bo Qin, Frank A Sinicrope
USP10 regulates ZEB1 ubiquitination and protein stability to inhibit ZEB1-mediated colorectal cancer metastasis. Molecular cancer research : MCR (2023)
Chao Zhang, Qiang Guo, Lifeng Chen, Zheming Wu, Xiao-Jian Yan, Chengyang Zou, Qiuxue Zhang, Jiahong Tan, Tian Fang, Qunxian Rao, Yang Li, Shizhen Shen, Min Deng, Liewei Wang, Huanyao Gao, Jia Yu, Hu Li, Cheng Zhang, Somaira Nowsheen, Jake A Kloeber, Fei Zhao, Ping Yin, Chunbo Teng, Zhongqiu Lin, Kun Song, Shuzhong Yao, Liangqing Yao, Lingying Wu, Yong Zhang, Xiaodong Cheng, Qing-Lei Gao, Jian Yuan, Zhenkun Lou, Jin-San Zhang
A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors. Signal transduction and targeted therapy 8 (1) (2023)
Lixuan Wei, Huanyao Gao, Jia Yu, Huan Zhang, Thanh Thanh Le Nguyen, Yayun Gu, Marie R Passow, Jodi M Carter, Bo Qin, Judy C Boughey, Matthew P Goetz, Richard M Weinshilboum, James N Ingle, Liewei Wang
Pharmacological targeting of androgen receptor elicits context-specific effects in estrogen receptor-positive breast cancer. Cancer research (2022)
Jia Yu, Bo Qin, Ann M Moyer, Somaira Nowsheen, Xinyi Tu, Haidong Dong, Judy C Boughey, Matthew P Goetz, Richard Weinshilboum, Zhenkun Lou, Liewei Wang
Regulation of sister chromatid cohesion by nuclear PD-L1. Cell research 30 (7) (2020)
August J John, Bo Qin, Krishna R Kalari, Liewei Wang, Jia Yu
Patient-specific multi-omics models and the application in personalized combination therapy. Future oncology (London, England) 16 (23) (2020)
Bo Qin, Jia Yu, Somaira Nowsheen, Fei Zhao, Liewei Wang, Zhenkun Lou
STK38 promotes ATM activation by acting as a reader of histone H4 ufmylation. Science advances 6 (23) (2020)
Bo Qin, Jia Yu, Somaira Nowsheen, Minghui Wang, Xinyi Tu, Tongzheng Liu, Honglin Li, Liewei Wang, Zhenkun Lou
UFL1 promotes histone H4 ufmylation and ATM activation. Nature communications 10 (1) (2019)

Jia Yu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jia Yu